Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-07
1994-04-05
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549407, 548209, 548210, C07D40906, A61K 3138
Patent
active
053005236
ABSTRACT:
For binding 5-HT.sub.1 receptors and thereby treating central nervous system disorders, novel substituted aminomethyltetralins and their heterocyclic analogues of the formula ##STR1##
REFERENCES:
patent: 4728650 (1988-03-01), Eziri et al.
patent: 4748182 (1988-05-01), Hibert et al.
patent: 5137901 (1992-08-01), Junge et al.
patent: 5185364 (1993-02-01), De Bernardis et al.
Chemical Abstracts, vol. 118 (3): 22144(g) 1992.
Chemical Abstracts, vol. 113(13):115087(c) (1990).
Benz Ulrich
De Vry Jean-Marie Viktor
Glaser Thomas
Junge Bodo
Schohe Rudolf
Bayer Aktiengesellschaft
Rizzo Nicholas S.
LandOfFree
Substituted aminomethyltetralins and their heterocyclic analogue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted aminomethyltetralins and their heterocyclic analogue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aminomethyltetralins and their heterocyclic analogue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-511341